<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Another terpene described in the articles was linalool (3,7-dimethylocta-1,6-dien-3-ol), which was investigated to assess its ability to reduce 
 <italic class="italic">P. multocida</italic>-induced lung inflammation. Repeated subcutaneous administration of linalool reduced the levels of TNF-
 <italic class="italic">α</italic> and IL-6 and the number of polymorphs (neutrophils) in lung tissue, associated with an increase in SOD [
 <xref rid="B34" ref-type="bibr" class="xref">34</xref>, 
 <xref rid="B94" ref-type="bibr" class="xref">94</xref>]. Eucalyptol (1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane) was also evaluated in a model of chronic lung inflammation induced by repeated exposure to cigarette smoke, where the treatment reduced the expression of NF-
 <italic class="italic">κ</italic>B and consequently the levels of proinflammatory cytokines, promoting the reduction of the presence of leukocytes in the pulmonary alveoli. The levels of antioxidant enzymes SOD, CAT, MDA, and GSH, as well as total ROS were reduced [
 <xref rid="B46" ref-type="bibr" class="xref">46</xref>].
</p>
